Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

Name: Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
Published: 2022
License: Public Domain

Hebei Senlang Biotechnology Inc., Ltd. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

t-cell acute lymphoblastic leukemia/lymphoma, t-all, t-lbl, cd7, car-t, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

Related documents